Corrigendum: Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China

Corrigendum: Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China

Bibliographic Details
Main Authors:	Jingyun Tang, Humin Liu, Qing Wang, Xiaobo Gu, Jia Wang, Wenjun Li, Yinglan Luo, Yan Li, Lan Deng, Yue Luo, Xinman Du, Donglin Tan, Xuemei Fu, Xue Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Immunology
Subjects:	SARS-CoV-2 IgG titer convalescent plasma screening COVID-19 Chinese cross-sectional study whole-blood donors
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1327039/full

Similar Items

Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China
by: Jingyun Tang, et al.
Published: (2023-06-01)

A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
by: Hiraku Sasaki, et al.
Published: (2019-09-01)

Analysis of related factors of plasma antibody titer in convalescent patients with COVID-19
by: Xin HU, et al.
Published: (2023-09-01)

ABO isoagglutinin titers in group “O” blood donors
by: Sadhana Mangwana, et al.
Published: (2024-12-01)

Cytokine profile depending on titers of anti-SARS-CoV-2 IgG in the blood plasma of healthy volunteers
by: Daryna Krenytska, et al.
Published: (2023-12-01)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
by: Xu Song, et al.
Published: (2023-06-01)

Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors: a Chinese cross-sectional study
by: Donglin Tan, et al.
Published: (2024-03-01)

Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
by: Llipsy Santiago, et al.
Published: (2021-03-01)

Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
by: Katerina Jazbec, et al.
Published: (2023-03-01)

Predictive Analysis of the Neutralization Activity in Convalescent Plasmas From COVID-19 Recovered Patients in Zhejiang Province, China, January-March, 2020
by: Yajie Yuan, et al.
Published: (2021-03-01)

Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan
by: Hiraku Sasaki, et al.
Published: (2021-09-01)

Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation
by: Hyung Park, et al.
Published: (2024-06-01)

A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors—Implications for Measles Post-Elimination Countries
by: Kirsten M. Williamson, et al.
Published: (2024-07-01)

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors
by: Mallikarjuna R. Gedda, et al.
Published: (2022-12-01)

Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey
by: Mustafa Yilmaz, et al.
Published: (2021-06-01)

Dangerous universal donors: the reality of the Hemocentro in Belo Horizonte, Minas Gerais
by: Mariana Martins Godin, et al.

Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar
by: Devendra Bansal, et al.
Published: (2023-02-01)

West Nile virus IgG antibodies among blood donors in Sudan: a cross-sectional study
by: Yasir Ezzeldien Salih Amin, et al.
Published: (2022-11-01)

Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
by: Daniele Focosi, et al.
Published: (2021-02-01)

Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021
by: Anita Siller, et al.
Published: (2022-03-01)

Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients
by: MEENU BAJPAI, et al.
Published: (2022-09-01)

Increased parvovirus B19 seropositivity in healthy blood donors in India
by: Swati Kumari, et al.
Published: (2024-09-01)

Extensive characterization of COVID-19 convalescent plasma from Bulgarian donors
by: Vancho Donev, et al.
Published: (2024-12-01)

Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection
by: Nikolaos Orologas-Stavrou, et al.
Published: (2020-12-01)

The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study
by: Allen Widysanto, et al.
Published: (2022-12-01)

Outcomes of ABO-Incompatible kidney transplantation with respect to baseline isoagglutinin immunoglobulin G titers: A retrospective observational study
by: Lovy Gaur, et al.
Published: (2022-01-01)

First Indian initiative for preparation of low-titer group “O” single-donor platelets with platelet additive solution
by: Puneet Jain, et al.
Published: (2018-01-01)

SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala
by: Maylin Pérez-Bernal, et al.
Published: (2022-12-01)

Selective Immunoglobulin A Deficiency in Iranian Blood Donors: Prevalence, Laboratory and Clinical Findings
by: Saghafi Shiva, et al.
Published: (2008-09-01)

The Seropositivity Rate of Human Cytomegalovirus [Hcmv] Among Hepatitis B Virus [Hbv] Patients, Hepatitis C Virus [Hcv] Patients, and Blood Donors in Diyala Province
by: Dhaffir Hashim Steer, et al.
Published: (2024-01-01)

The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated
by: Serdar EFE, et al.
Published: (2024-02-01)

Multistep screening and selection of COVID‐19 convalescent plasma donors at the early stage of the SARS‐CoV‐2 pandemic: A retrospective analysis
by: Andreas M. Brosig, et al.
Published: (2022-09-01)

Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches
by: Sanja Mateljak Lukačević, et al.
Published: (2020-12-01)

Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks
by: Tihana Kurtović, et al.
Published: (2022-05-01)

Laparoscopic live donor nephrectomy in the context of the Indian subcontinent
by: Hari Siva T Gurunadha Rao, et al.
Published: (2000-01-01)

Quantitative immunoassay for mink immunoglobulin in serum and milk
by: Ronja Mathiesen, et al.
Published: (2018-06-01)

Increased antibody titers but induced T cell AICD and apoptosis response in COVID-19 convalescents by inactivated vaccine booster
by: Jingmin Zhao, et al.
Published: (2024-03-01)

Immunoglobulin G4‐related disease in a dog
by: Lydia J. Colopy, et al.
Published: (2019-11-01)

Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01)